Jan 30, 2014, 12:40 PM by Michael Croft

Xconomy | Johnson & Johnson today announced that an independent group at Yale will be empowered to review and grant scientific requests to see the full results of any clinical trial in the company's records.

Jan 30, 2014, 12:20 PM by Michael Croft

Bio-IT World | GenePeeks, preparing to launch its service minimizing the risk of genetic disorders in children conceived through sperm donors, is awarded a patent for algorithms that create "digital children" from parental genotypes.

Jan 30, 2014, 08:00 AM by Michael Croft

Bio-IT World News Brief | Dassault Systèmes, a French company focused on Product Lifecycle Management (PLM), 3D design software and 3D digital Mock Up, announced its definitive agreement to acquire Accelrys last night in an all cash tender offer, representing a fully diluted equity value for Accelrys of approximately $750 million.

Jan 30, 2014, 00:00 AM by Michael Croft

NEEDHAM, MA - Cambridge Healthtech Institute (CHI) announces today the acquisition of the Knowledge Foundation, Inc.

Jan 30, 2014, 00:00 AM by Michael Croft

NEEDHAM, MA - Insight Pharma Reports announces Prenatal Diagnostics: Invasive testing, noninvasive testing, and rising maternal screening methods for preeclampsia and preterm labor report.  The newly released Insight Pharma Report discusses improvements in invasive procedures (karyotyping vs. cytogenetics), and the rise of noninvasive screening methods and their impact on prenatal healthcare.

Jan 29, 2014, 12:55 PM by Michael Croft

Bio-IT World | As a new generation of gene editing technologies like CRISPR and TALEN emerges, the founders of Editas Medicine think the time is right to forge ahead with gene therapy.

Jan 28, 2014, 07:00 AM by Michael Croft

Bio-IT World | In a paper published in Nature last week, Broad researchers identified 33 new point mutations associated with cancer and estimated that mutations associated with at least 10% of cancer cases have been IDd. The next step is to find those mutations involved in only 5% or 2% of cancers.

Jan 27, 2014, 09:10 AM by Michael Croft

Bio-IT World | It's been almost five years since the Genome Reference Consortium released a brand-new assembly of the human reference genome. The NCBI's Valerie Schneider tells Bio-IT World what "build 38" brings to the table.

Jan 24, 2014, 13:35 PM by Michael Croft

Bio-IT World | Adding to the complex picture of schizophrenia's genetics is a recent study from Iceland, looking at those individuals who carry mutations that have been linked to schizophrenia – but who have not been diagnosed with the disorder.

Jan 24, 2014, 13:00 PM by Michael Croft

Computerworld | HP is launching a suite of data center infrastructure management services based on the company's DCIM best practices that they call the Converged Management Framework.

Jan 24, 2014, 00:00 AM by Michael Croft

BERGISCH GLADBACH, GERMANY - Miltenyi Biotec announced today that the U.S. Food and Drug Administration (FDA) has approved the company’s CliniMACS CD34 Reagent System as a Humanitarian Use Device for the prevention of graft-versus-host disease (GVHD) in patients with acute myeloid leukemia (AML) in first complete remission undergoing allogeneic stem cell transplantation (SCT) from a matched related donor

Jan 22, 2014, 13:20 PM by Michael Croft

Bio-IT World | The publication of the two largest genetic studies of schizophrenia ever undertaken points to several areas of the genome as key to understanding the disease. But the research also highlights just how difficult the genetics of this complicated disorder are to untangle.

Jan 22, 2014, 10:00 AM by Michael Croft

Bio-IT World | The NIH’s Undiagnosed Diseases Program has turned their diploid aligner tool over to Appistry to make the pipeline “production-ready.” Appistry will host the tool in their cloud, and make the pipeline available to other users with commercial-grade support.

Jan 20, 2014, 08:00 AM by Michael Croft

Xconomy | Luke Timmerman sees a power shift in biotech and sums up last week's JP Morgan Healthcare Conference in one line: "It's the healthiest environment for innovation that I've seen in years."

Jan 17, 2014, 14:00 PM by Michael Croft

Bio-IT World | At Aspera, it’s business as usual, Michelle Munson told Bio-IT World this morning, after the announcement that the software company’s acquisition by IBM closed. Aspera’s software development is focused on continuing to increase raw performance; improving ease of use; integration; and developing its software developer kit and APIs.

Jan 16, 2014, 09:15 AM by Michael Croft

Bloomberg | A U.S. government-funded program is enabling hundreds of infants' genomes to be sequenced in medical centers around the country.

Jan 15, 2014, 14:00 PM by Michael Croft

Nature | Robert Green and Nita Farahany take on the FDA's treatment of 23andMe in a Nature comment today. "[R]egulatory constraints might stifle consumer genomics..." the two warned.

Jan 15, 2014, 12:00 PM by Michael Croft

Bio-IT World News Brief | Since QIAGEN acquired Ingenuity Systems, Ingenuity has since been trading under the name QIAGEN Redwood City, but QIAGEN has announced that the company will now be branded as such as well.

Jan 15, 2014, 11:00 AM by Michael Croft

Jan 15, 2014, 08:00 AM by Michael Croft

Forbes | Matthew Herper gets Merck on the phone to discuss strategy, the FDA, and organizational changes.